Patrick Grohar
Children's Hospital of Philadelphia
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Patrick Grohar as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:01 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04067115 · SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma PatientsSarcoma Alliance for Research through Collaboration · completed · Ewing Sarcoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- A collaborative approach to analyze and target the EWS-FLI1 transcription factor in patients with Ewing sarcomaU01CA236220 · NCI · SARC · fiscal years 2019 to 2023 · $111,060 awarded in 2023Grant number is on one of their registry trials
- Development of Trabectedin Analogs that Target the EWS-FLI1 Transcription FactorR01CA188314 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · fiscal years 2015 to 2019 · $351,468 awarded in 2019Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name in ewing sarcoma, ranked by citations from NIH iCite, fetched 2026-11-12 08:01 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed
- A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS-FLI1 fusion transcript.Cancer Chemother Pharmacol · 201770 citationsRCR 2.5
- Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031.J Clin Oncol · 202326 citationsRCR 2.7